Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Circulation
|
April 2, 2003
Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes
Tomosaburo Takahashi, Bernadette Lord, P Christian Schulze, et al.
International Journal of Pharmaceutics
|
August 21, 2016
Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection
Yin-Chao Tseng, Brian Linehan, Khing Jow Ng, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 25, 2006
Cardiovascular disease in chronic kidney failure: the role of VDR activators
J Ruth Wu-Wong, Jin Tian, Masaki Nakane, et al.
Plos One
|
June 4, 2016
Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
Hu Sheng Qian, Steve M Weldon, Damian Matera, et al.
Journal of Pharmacological and Toxicological Methods
|
March 8, 2011
Functional biomarkers of musculoskeletal syndrome (MSS) for early in vivo screening of selective MMP-13 inhibitors
Suzanne G Nodop Mazurek, Jun Li, Gerald H Nabozny, et al.
Experimental Nephrology
|
April 9, 2002
Global analysis of gene expression: methods, interpretation, and pitfalls
Ryan M Fryer, Jeffrey Randall, Takumi Yoshida, et al.
Nephron. Physiology
|
July 12, 2007
Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice
Ryan M Fryer, Pamela A Rakestraw, Masaki Nakane, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 6, 2007
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs
Patricia N Banfor, Lee C Preusser, Thomas J Campbell, et al.
Clinical and Experimental Pharmacology & Physiology
|
February 1, 2006
Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents
Lee C Preusser, Ryan M Fryer, Armin Gerhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 25, 2023
Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model
Amanda K Jones, Hongxing Chen, Khing Jow Ng, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Circulation
|
April 2, 2003
Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes
Tomosaburo Takahashi, Bernadette Lord, P Christian Schulze, et al.
International Journal of Pharmaceutics
|
August 21, 2016
Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection
Yin-Chao Tseng, Brian Linehan, Khing Jow Ng, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 25, 2006
Cardiovascular disease in chronic kidney failure: the role of VDR activators
J Ruth Wu-Wong, Jin Tian, Masaki Nakane, et al.
Plos One
|
June 4, 2016
Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
Hu Sheng Qian, Steve M Weldon, Damian Matera, et al.
Journal of Pharmacological and Toxicological Methods
|
March 8, 2011
Functional biomarkers of musculoskeletal syndrome (MSS) for early in vivo screening of selective MMP-13 inhibitors
Suzanne G Nodop Mazurek, Jun Li, Gerald H Nabozny, et al.
Experimental Nephrology
|
April 9, 2002
Global analysis of gene expression: methods, interpretation, and pitfalls
Ryan M Fryer, Jeffrey Randall, Takumi Yoshida, et al.
Nephron. Physiology
|
July 12, 2007
Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice
Ryan M Fryer, Pamela A Rakestraw, Masaki Nakane, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 6, 2007
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs
Patricia N Banfor, Lee C Preusser, Thomas J Campbell, et al.
Clinical and Experimental Pharmacology & Physiology
|
February 1, 2006
Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents
Lee C Preusser, Ryan M Fryer, Armin Gerhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 25, 2023
Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model
Amanda K Jones, Hongxing Chen, Khing Jow Ng, et al.
Page
of 5